lunes, 24 de noviembre de 2014

Genomics|Update|Current: Pharmacogenomics


Genomics & Health Impact Update

Evidence required to demonstrate clinical utility of pharmacogenetic testing: the debate continuesExternal Web Site Icon 
Gillis NK & Innocenti F Clin Pharmacol Ther 2014 Dec;96(6):655-7
Meaningful use of pharmacogeneticsExternal Web Site Icon
M J Ratain and J A Johnson Clinical Pharmacology & Therapeutics (2014); 96 6, 650–652.
Useless until proven effective: The clinical utility of preemptive pharmacogenetic testingExternal Web Site Icon
A C J W Janssens and P A Deverka Clinical Pharmacology & Therapeutics (2014); 96 6, 652–654.

No hay comentarios:

Publicar un comentario